#Downgrades - Mar 03, 2025 • $AGCO: Baird Downgrades to Neutral from Outperform - PT $100 (from $116) • $CNH: Baird Downgrades to Neutral from Outperform - PT $15 (from $16) • $DE: Baird Downgrades to Neutral from Outperform - PT $501 • $DG: Deutsche Bank Downgrades to Hold from Buy - PT $80 (from $90) • $DV: Cannonball Research Downgrades to Neutral from Buy - PT $14 • $FOX: Arete Downgrades to Neutral from Buy - PT $66 • $FTAI: Stifel Downgrades to Hold from Buy - PT $123 (from $100) • $KC: Nomura Downgrades to Neutral from Buy - PT $18.10 (from $6.70) • $KRP: Raymond James Downgrades to Market Perform from Strong Buy • $LUV: JPMorgan Downgrades to Underweight from Neutral - PT $25 • $SRE: Jefferies Downgrades to Hold from Buy - PT $77 (from $96) • $TNDM: Bernstein Downgrades to Market Perform from Outperform - PT $25 (from $35) • $TNDM: Wells Fargo Downgrades to Equal Weight from Overweight - PT $22 (from $38) • $ZLAB: BofA Securities Downgrades to Neutral from Buy - PT $36.10 (from $29)

MORNING BID 🔸 Nvidia ( $NVDA): • Q4 adj. EPS $0.89 (est. $0.84) • revs $39.33B (est. $38.05B) • Data center revs $35.6B (+93%) • Auto $570M (+103%) • Gaming $2.5B (-11%) • Q1 revs $43B ±2% (est. $41.78B). 🔸 Amazon ( $AMZN): Debuted Ocelot, its first quantum computing chip. 🔸 Snowflake ( $SNOW): • Q4 EPS $0.30 (est. $0.18) • revs $986.8M (+28%, est. $956.26M) • Q1 product revs guidance $955M-$960M (est. $962.6M); expanded Microsoft partnership. 🔸 Salesforce ( $CRM) • Q4 adj. EPS $2.78 (est. $2.61) • revs $9.99B (missed est. $10.04B) • Q1 guidance below consensus: EPS $2.53-$2.55, revs $9.71B-$9.76B. 🔸 https://t.co/dPTowbRrks ( $AI): • Q3 EPS -$0.12 (est. -$0.25) • revs $98.8M (+26%, est. $98.1M) • Q4 revs guidance $103.6M-$113.6M (est. $108.6M). 🔸 Magnite ( $MGNI) Q4 adj. EPS $0.34 (est. $0.36) revs $194M (est. $184.3M) FY adj. EBITDA guidance mid-teens % (est. +12.8%). 🔸 Nutanix ( $NTNX) Q2 adj. EPS $0.56 (est. $0.47) revs $654.7M (est. $641.86M) Q3 revs guidance $620M-$630M (est. $594.39M). 🔸 eBay ( $EBAY) Q4 adj. EPS $1.25 (est. $1.20) revs $2.6B (est. $2.58B) GMV $19.3B (+4%) Q1 adj. EPS guidance $1.32-$1.36 (est. $1.33) revs $2.52B-$2.56B (est. $2.59B) GMV $18.3B-$18.6B. 🔸 Paramount ( $PARA): Q4 revs $7.98B (est. $8.1B); Paramount+ added 5.6M subs (est. 2.58M). 🔸 Pure Storage ( $PSTG): Q4 EPS $0.45 (est. $0.42), revs $879.8M (est. $869.19M); FY revs guidance $3.515B (est. $3.52B). 🔸 Synopsys ( $SNPS): Q1 EPS $3.03 (est. $2.79), revs $1.46B (est. $1.45B); FY EPS guidance $14.88-$14.96 (est. $14.89). 🔸 TaskUs ( $TASK): Q4 EPS $0.31 (est. $0.34), revs $274.2M (est. $268.8M); FY adj. EBITDA margin ~21%. 🔸 TKO Group ( $TKO): Q4 EPS $0.28 (est. $0.21), revs $642.2M (est. $604M); FY adj. EBITDA $1.35B-$1.39B (FY24: $1.25B). 🔸 Norwegian Cruise Line ( $NCLH): Q4 adj. EPS $0.26 (est. $0.11), revs $2.11B (in line); Q1 Net Yield expected to rise ~0.5% y/y (constant currency). 🔸 Urban Outfitters ( $URBN): Q4 adj. EPS $1.04 (est. $0.94), revs $1.64B (+10%, est. $1.61B); Retail segment sales +6.3%, driven by digital and store growth. 🔸 Agilent ( $A): Q1 adj. EPS $1.31 (est. $1.27), revs $1.68B (est. $1.67B); Q2 guidance below estimates; FY25 revs cut to $6.68B-$6.76B (est. $6.82B). 🔸 CareDx ( $CDNA): Q4 adj. EPS $0.18 (est. $0.15), revs $86.6M (est. $84.56M); FY25 revs guidance $365M-$375M (est. $370.02M); Testing services revs +37% y/y. 🔸 Catalyst Pharma ( $CPRX): Q4 EPS $0.70 (est. $0.55), revs $141.8M (+28%, est. $134.2M); FY revs guidance $545M-$565M (est. $558.1M). 🔸 Outset Medical ( $OM): Filed $100M mixed securities shelf. 🔸 Sarepta ( $SRPT): Q4 adj. EPS $1.90 (in line), revs $658.4M (est. $627.58M). 🔸 Teladoc ( $TDOC): Q4 EPS -$0.28 (est. -$0.24), revs $640.49M (est. $639.55M); FY revs and EBITDA guidance below estimates. 🔸 Tandem Diabetes ( $TNDM): Q4 EPS $0.01 (est. -$0.23), revs $282.6M (est. $251.98M); FY revs guidance $997M-$1.007B (est. $1.008B). 🔸 Universal Health ( $UHS): Q4 adj. EPS $4.92 (est. $4.18), revs $4.11B (est. $4.01B); FY revs and EBITDA guidance above estimates.

MOVING UP $GAP surged 5% after an upgrade to Overweight from Neutral by JP Morgan, with a new price target of $30. They revised their FY25 EPS to $2.30 and FY26 EPS to $2.53, expecting revenue growth and margin expansion. $INTC rose 2% on CEO Pat Gelsinger's retirement announcement. David Zinsner and Michelle Johnston Holthaus are appointed interim Co-CEOs, with Frank Yeary as Interim Executive Chair while a permanent successor is sought. $NBIS soared 16% after securing $700M through a private placement involving NVDA, planning to issue 33.33M Class A shares at $21/share. $NVCR jumped 30% following successful trial results where its cancer therapy, combined with chemotherapy, extended pancreatic cancer patient survival from 14.16 to 16.20 months on average. $PTCT climbed 14% after licensing its experimental Huntington's Disease drug, PTC518, to a Novartis unit for up to $2.9B, with $1B upfront. $SMCI increased 14% after confirming no need to restate financials, with no evidence of shipping incomplete products to boost quarterly revenue. $TNDM went up 6% after an upgrade to Overweight from Equal Weight by Morgan Stanley, with a $45 price target, citing undervalued stock and potential in type-2 diabetes market expansion. $TSLA gained 2% with Stifel maintaining its Buy rating, raising the target to $411, praising Tesla's broader market vision beyond just being an automaker. Additionally, Roth MKM upgraded TSLA to Buy, setting a $380 target, highlighting potential catalysts for value increase. MOVING DOWN $CORZ drops 5% on news of a $500M convertible senior notes offer for 2031. $NU falls 5%, hit by Citigroup's downgrade to Sell, citing profit-taking despite strong growth in Brazil. $PCG slides 5% after announcing $2.4B in stock offerings. $STLA tumbles 8% following CEO Carlos Tavares' sudden resignation after nearly four years. $UPST plunges 11%, downgraded to Underweight at JP Morgan, with caution advised on fintech at current valuations.

DAILY RECAP **BYD Co. ( $BYDDF)** reported a 67.8% y/y increase in November vehicle sales, reaching 506,804 units compared to 301,903 last year. Year-to-date sales hit 3.76M units, up from 2.68M last year. **Gap ( $GAP)** received an upgrade to overweight from neutral by JPMorgan after a CEO and CFO meeting. **Li Auto Inc. ( $LI)** delivered 48,740 vehicles in November 2024, a y/y increase of 18.8%, with a 2024 total of 441,995 and cumulative deliveries at 1,075,359. **NIO Inc. ( $NIO)** saw a 28.9% y/y rise in November deliveries to 20,575 vehicles, split between its NIO and ONVO brands. **Stellantis ( $STLA)** announced CEO Carlos Tavares' resignation, effective immediately, with a new CEO search set to conclude in 2025's first half. **XPeng Inc. ( $XPEV)** delivered 30,895 Smart EVs in November, up 54% y/y and 29% m/m, with strong sales of the MONA M03 and P7+. **Core Scientific Inc. ( $CORZ)** plans to issue $500M in convertible senior notes maturing in 2031. **IREN Limited ( $IREN)** boosted its self-mining capacity by 33% to 28 EH/s with new substation energization. **LendingClub ( $LC)** was downgraded to neutral by JPMorgan due to fintech sector concerns. **Mara Holdings ( $MARA)** is set to offer $700M in zero-coupon convertible senior notes privately. **Toast ( $TOST)** received a downgrade to Neutral from Goldman Sachs, citing high valuation and visibility issues. **Upstart Holdings ( $UPST)** was downgraded to underweight by JP Morgan. **Bausch + Lomb ( $BLCO)** was downgraded to Equal Weight by Morgan Stanley. **Nevro ( $NVRO)** saw a downgrade to Underweight by Morgan Stanley. **Tandem Diabetes ( $TNDM)** got an upgrade to Overweight from Morgan Stanley. **Cloudflare ( $NET)** was upgraded to overweight by Morgan Stanley, optimistic about future growth. **SentinelOne ( $S)** was downgraded to equal weight by Morgan Stanley, due to cybersecurity sector concerns. **U.S. to implement new export restrictions on Monday targeting China's semiconductor sector**, affecting companies like Naura Technology Group, potentially impacting shares of $AMAT, $LRCX, $KLAC.